Michael David Alpert

NIH Rank #3037
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 12543320Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2025Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

NIH Funding · FY2025

Linked Award Amount
$3.2M
Full award amounts, FY2025
Award Records
4
Records listing this PI
Award-Linked Rank
#3,037
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Michael David Alpert as a PI. Multi-PI records show the full award amount for context.

  • 5R44AI170392-04R44
    SARS-CoV-2 vaccines based on RBDs with engineered glycosylation sites
    $1M
    award amount
  • 4R44AI170285-02R44
    Process development for manufacturing eCD4-Ig
    $1M
    award amount
  • 1R56AI189343-01R56
    Non-viral gene therapy with eCD4-Ig
    $917.3K
    award amount
  • 1R43AI191927-01R43
    IND-enabling studies for eCD4-Ig as a long-acting recombinant protein therapeutic
    $300K
    award amount

Award organization

Organizations that administered FY2025 awards listing Michael David Alpert as a PI.

FY2025 award administered by Emmune, Inc (FL).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    ScienceDex Coverage Begins
    Earliest loaded PI award records: FY2024
  2. 2024
    $500K Cumulative Linked Award Amount
  3. 2024
    $1M Cumulative Linked Award Amount
  4. 2024
    $2M Cumulative Linked Award Amount
  5. 2024
    Reached Top 50% by Award-Linked Rank
    Ranked #3148
  6. 2024
    Reached Top 25% by Award-Linked Rank
    Ranked #3148
  7. 2025
    $5M Cumulative Linked Award Amount